Regeneron Pharmaceuticals' Change in Inventory fell 10178.42% to -$2.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $275.3 million, marking a year-over-year decrease of 5557.53%. This contributed to the annual value of $275.3 million for FY2025, which is 5557.53% down from last year.
As of Q4 2025, Regeneron Pharmaceuticals' Change in Inventory stood at -$2.1 million, which was down 10178.42% from $82.6 million recorded in Q3 2025.
In the past 5 years, Regeneron Pharmaceuticals' Change in Inventory registered a high of $252.8 million during Q1 2021, and its lowest value of -$31.3 million during Q2 2021.
For the 5-year period, Regeneron Pharmaceuticals' Change in Inventory averaged around $117.9 million, with its median value being $113.4 million (2021).
As far as peak fluctuations go, Regeneron Pharmaceuticals' Change in Inventory crashed by 11924.97% in 2021, and later soared by 86709.27% in 2022.
Over the past 5 years, Regeneron Pharmaceuticals' Change in Inventory (Quarter) stood at $163.7 million in 2021, then decreased by 11.85% to $144.3 million in 2022, then crashed by 67.22% to $47.3 million in 2023, then surged by 148.84% to $117.7 million in 2024, then tumbled by 101.78% to -$2.1 million in 2025.
Its Change in Inventory was -$2.1 million in Q4 2025, compared to $82.6 million in Q3 2025 and $42.5 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value